MENU
IBIO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

iBio (IBIO) Ownership - Who owns iBio?

iBio Inc is a clinical-stage biotechnology company using Artificial Intelligence (AI) for the development of hard-to-drug precision antibodies for obesity, cardiometabolic, and cardiopulmonary diseases... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
11750 Sorrento Valley Road
Phone
+1 979 446-0027
Employees
23
Web
https://www.ibioinc.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
77.49M
P/E Ratio
0.65
Total Cash
88.04M
Projected Growth
N/A
Total Debt
2.2M
Revenue
100K
Risk (Beta)
0.32
Dividend Yield
N/A
Total Cash/Share
1.37
Total Debt/Equity
N/A
Revenue/Share
0.00 USD as % of share price
View a ticker or compare two or three
IBIO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a company which engages in the development and commercialization of vaccines and therapeutic proteins

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
11750 Sorrento Valley Road
Phone
+1 979 446-0027
Employees
23
Web
https://www.ibioinc.com
Who owns iBio? IBIO symbol Ownership - Tickeron.com